MSc in Cancer Pharmacology in London United Kingdom | London Metropolitan University

London Metropolitan University's Master's program in Cancer Pharmacology delves into cancer's mechanisms across systems, cells, and molecules, emphasizing therapeutic drugs and their mechanisms of action. Upon completing this MSc, you'll gain comprehensive knowledge about how chemotherapy agents specifically target and eliminate cancer cells as a core treatment approach.

Given the global rise in cancer cases, projected to hit 22 million annual diagnoses by 2030, this advanced program examines the critical roles of radiotherapy, surgery, and chemotherapy in extending patient survival.

The curriculum offers thorough insights into molecular targets of various anticancer drug categories and the ongoing evolution of treatment protocols. You'll also examine cancer biology through the lenses of genetics, pathology, and cellular molecular changes linked to disease progression.

Instruction comes from faculty actively engaged in cancer biology, immunology, genetics, and bioinformatics research. They'll guide you in mastering data collection, analysis, and interpretation essential for cancer pharmacology work, enhancing both your theoretical understanding and hands-on expertise.